Status:
RECRUITING
Positive Processes and Transition to Health - Single-Session (PATH-SS)
Lead Sponsor:
Case Western Reserve University
Conditions:
PTSD
Depression
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test a brief, new psychotherapy (called Positive Processes and Transition to Health - Single Session, or PATH-SS) that aims to provide relief for people who are s...
Detailed Description
This study will be an open trial to determine if PATH-SS reduces stressor-related symptoms of PTSD and/or depression after sexual assault in a sample of 45 college students who have experienced a sexu...
Eligibility Criteria
Inclusion
- Age range: from 18 to 65.
- Has experienced unwanted sexual contact or sexual assault during their time as a college student, with a minimum of 12 weeks since the event and a maximum of 5 years since the event.
- Enrolled in any undergraduate, graduate, or professional program at a college or university in the state of Ohio.
- Elevated symptoms on either the Posttraumatic Diagnostic Scale (PDS-5) or the Quick Inventory of Depressive Symptomatology (QIDS-SR), at least moderate: 18 on PDS-5 (Foa et al., 2016) and/or 11 on QIDS (moderate depression severity; Rush et al., 2003), with symptoms persisting for 1 month or longer.
Exclusion
- Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by DSM-5.
- Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
- Severe self-injurious behavior or suicide attempt within the previous three months.
- Currently engaged in cognitive behavioral psychotherapy.
- No clear memory of the event.
- Unstable dose of psychotropic medications in prior 3 months.
- Ongoing intimate relationship with the perpetrator.
- Current diagnosis of a substance use disorder (DSM-5).
- Residence outside the state of Ohio.
Key Trial Info
Start Date :
July 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06900712
Start Date
July 17 2025
End Date
May 31 2026
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Case Western Reserve University
Cleveland, Ohio, United States, 44106